Combining rituximab with mycophenolate for the treatment of interstitial lung disease

By sjmartinez • June 9, 2023

Volkmann ER. Combining rituximab with mycophenolate for the treatment of interstitial lung disease. Eur Respir J. 2023 Jun 8;61(6):2300614. doi: 10.1183/13993003.00614-2023. PMID: 37290812.

Tags: Publications, Rheumatology

Medical Therapy Before, During, and After Hospitalization in Medicare Beneficiaries with Heart Failure and Diabetes: The Get With The Guidelines – Heart Failure Registry

Bhatt AS, Fonarow GC, Greene SJ, Holmes DN, Alhanti B, DeVore AD, Butler J, Heidenreich PA, Huang JC, Kittleson MM, Linganathan K, Joynt Maddox KE, ...

Development and Optimization of the Veterans Affairs’ National Heart Failure Dashboard for Population Health Management

Brownell N, Kay C, Parra D, Anderson S, Ballister B, Cave B, Conn J, Dev S, Kaiser S, Rogers J, Touloupas AD, Verbosky N, Yassa ...

Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial

Calsavara VF, Henry NL, Hays RD, Kim S, Luu M, Diniz MA, Gresham G, Cecchini RS, Yothers G, Ganz PA, Rogatko A, Tighiouart M. Dynamic ...